Mr. Leary assists Tailwind in sourcing, evaluating and performing due diligence on healthcare opportunities. Mr. Burgess serves on the Board of Directors of Edenbridge and currently works with DermaRite.
Mr. Leary has over 20 years of experience within the pharmaceutical industry. Most recently, Mr. Leary served as the Chief Operating Officer of VersaPharm, a provider of generic pharmaceuticals which was previously a Tailwind portfolio company. While at VersaPharm, Mr. Leary was responsible for company's distribution services, product supply chain and administrative operations, as well as all finance and accounting activity. Prior to his time at VersaPharm, Mr. Leary served as Group Vice President of Finance and Corporate Controller of Taro Pharmaceuticals (NASDAQ: TARO), a multinational, generic pharmaceutical company.
Mr. Leary began his career at Pfizer (NYSE: PFE), as a member of the U.S. marketing team. Mr. Leary received an MBA from the Leonard N. Stern School of Business at New York University and a BS from Syracuse University.